Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
A-582941 is an agonist of a7 nicotinic acetylcholine receptors (nAChRs).1 It induces inward currents in Xenopus oocytes expressing the rat or human receptor (EC50s = 2.45 and 4.26 µM, respectively), which can be reversed by methyllycaconitine (Item No. 21398). A-582941 selectively binds to a7 nAChRs (Kis = 10.8 and 16.7 nM for the rat and human receptors, respectively) over a panel of greater than 75 receptors and ion channels, including muscarinic receptors, at 10 µM but does bind to the serotonin (5-HT) receptor subtype 5-HT3 (Ki = 154 nM). In vivo, A-582941 (12 mg/kg) improves cognitive deficits in the 3xTg transgenic mouse model of Alzheimer’s disease.2 It increases accuracy in the delayed match-to-sample (DMTS) test in rhesus monkeys when administered at a dose of 10 mg/kg.1
WARNING This product is not for human or veterinary use.
1. Broad-
2. α7 nicotinic receptor agonist enhances cognition in aged 3xTg-